Company Announcements

Total Voting Rights

Source: RNS
RNS Number : 6419X
Brave Bison Group PLC
30 April 2019
 

30 April 2019

Brave Bison Group plc

("Brave Bison" or the "Company")

 

Total Voting Rights

Brave Bison Group plc (AIM: BBSN), the social video company, announces that the Company's issued ordinary share capital as at the date of this announcement comprises 606,344,223 ordinary shares, with one voting right each. The Company does not hold any ordinary shares in treasury. Therefore, the total number of ordinary shares and voting rights in the Company is 606,344,223. 

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules. 

-ENDS-

For further information please contact: 

Brave Bison Group plc

Kate Burns, Chief Executive Officer

Via Newgate - 020 3757 688

 

Allenby Capital Limited - AIM Nominated Adviser and Broker

Jeremy Porter / Asha Chotai

Tel: 020 3328 5656

 

Newgate Communications

Elisabeth Cowell / Robin Tozer/ Fiona Norman

bravebison@newgatecomms.com

Tel: 020 3757 6880

 
About Brave Bison: 

Brave Bison is a social video company, proudly working with some of the biggest brands and most followed YouTube and Facebook talent in the world. Clients include P&G, Shell, PUMA and Hyundai. 

Brave Bison makes it simple for content owners, creators, brands, publishers and platforms to unlock the value of online video, whether on a licensed, ad-funded, direct to consumer or paid placement basis. 

The business is based in two regions - Europe, with headquarters in London; and APAC, with offices in Singapore.

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRWGUAPCUPBGQU